Impact of targeting the platelet-activating factor and its receptor in cancer treatment
REVIEW|Updated:2025-12-13
|
Impact of targeting the platelet-activating factor and its receptor in cancer treatment
“In the field of cancer treatment, the lipid mediator platelet-activating factor (PAF) and its receptor (PAFR) signaling pathway is a promising target. Expert xx explored the PAF/PAFR signaling pathway, which provides solutions to solve cancer treatment problems and lays a foundation for the construction of cancer treatment system.”
Military Medical ResearchVol. 12, Issue 10, Pages: 1617-1644(2025)
Affiliations:
1.Department of Molecular and Cell Biology, College of Life Sciences, University of Leicester, University Road, Leicester LE1 7RH, UK
2.Department of Laboratory Medicine, Faculty of Paramedical, Kurdistan University of Medical Sciences, Sanandaj 66177-13446, Kurdistan, Iran
3.Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University, Dayton, OH 45435, USA
Kimya Qaderi, Arvin Shahmoradi, Anita Thyagarajan, et al. Impact of targeting the platelet-activating factor and its receptor in cancer treatment[J]. Military Medical Research, 2025, 12(10): 1617-1644.
DOI:
Kimya Qaderi, Arvin Shahmoradi, Anita Thyagarajan, et al. Impact of targeting the platelet-activating factor and its receptor in cancer treatment[J]. Military Medical Research, 2025, 12(10): 1617-1644. DOI: 10.1186/s40779-025-00597-0.
Impact of targeting the platelet-activating factor and its receptor in cancer treatment